Compile Data Set for Download or QSAR
maximum 50k data
Report error Found 747 with Last Name = 'pizzirani' and Initial = 'd'
TargetGlutamate receptor ionotropic, NMDA 2B(Rat)
Istituto Italiano Di Tecnologia

Curated by ChEMBL
LigandPNGBDBM50007674((+)-erythro 4-[2-(4-Benzyl-piperidin-1-yl)-1-hydro...)
Affinity DataKi:  29nMAssay Description:Displacement of [3H]Ifenprodil from NMDAR-2B in Sprague-Dawley rat frontal cortex homogenates after 2 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
TargetGlutamate receptor ionotropic, NMDA 2B(Rat)
Istituto Italiano Di Tecnologia

Curated by ChEMBL
LigandPNGBDBM50398926(CHEMBL2178786)
Affinity DataKi:  2.90E+3nMAssay Description:Displacement of [3H]Ifenprodil from NMDAR-2B in Sprague-Dawley rat frontal cortex homogenates after 2 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rat)
Istituto Italiano Di Tecnologia

Curated by ChEMBL
LigandPNGBDBM50398918(CHEMBL2178778)
Affinity DataKi:  3.32E+3nMAssay Description:Displacement of [3H]Ifenprodil from NMDAR-2B in Sprague-Dawley rat frontal cortex homogenates after 2 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rat)
Istituto Italiano Di Tecnologia

Curated by ChEMBL
LigandPNGBDBM50398928(CHEMBL2178784)
Affinity DataKi:  4.60E+3nMAssay Description:Displacement of [3H]Ifenprodil from NMDAR-2B in Sprague-Dawley rat frontal cortex homogenates after 2 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rat)
Istituto Italiano Di Tecnologia

Curated by ChEMBL
LigandPNGBDBM50398924(CHEMBL2178788)
Affinity DataKi:  5.25E+3nMAssay Description:Displacement of [3H]Ifenprodil from NMDAR-2B in Sprague-Dawley rat frontal cortex homogenates after 2 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rat)
Istituto Italiano Di Tecnologia

Curated by ChEMBL
LigandPNGBDBM50398915(CHEMBL2178781)
Affinity DataKi:  9.76E+3nMAssay Description:Displacement of [3H]Ifenprodil from NMDAR-2B in Sprague-Dawley rat frontal cortex homogenates after 2 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rat)
Istituto Italiano Di Tecnologia

Curated by ChEMBL
LigandPNGBDBM50398927(CHEMBL2178785)
Affinity DataKi:  1.10E+4nMAssay Description:Displacement of [3H]Ifenprodil from NMDAR-2B in Sprague-Dawley rat frontal cortex homogenates after 2 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rat)
Istituto Italiano Di Tecnologia

Curated by ChEMBL
LigandPNGBDBM50398929(CHEMBL2178783)
Affinity DataKi:  4.09E+4nMAssay Description:Displacement of [3H]Ifenprodil from NMDAR-2B in Sprague-Dawley rat frontal cortex homogenates after 2 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rat)
Istituto Italiano Di Tecnologia

Curated by ChEMBL
LigandPNGBDBM50398922(CHEMBL2178790)
Affinity DataKi: >1.00E+5nMAssay Description:Displacement of [3H]Ifenprodil from NMDAR-2B in Sprague-Dawley rat frontal cortex homogenates after 2 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rat)
Istituto Italiano Di Tecnologia

Curated by ChEMBL
LigandPNGBDBM50398923(CHEMBL2178789)
Affinity DataKi: >1.00E+5nMAssay Description:Displacement of [3H]Ifenprodil from NMDAR-2B in Sprague-Dawley rat frontal cortex homogenates after 2 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rat)
Istituto Italiano Di Tecnologia

Curated by ChEMBL
LigandPNGBDBM50398917(CHEMBL2178779)
Affinity DataKi: >1.00E+5nMAssay Description:Displacement of [3H]Ifenprodil from NMDAR-2B in Sprague-Dawley rat frontal cortex homogenates after 2 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rat)
Istituto Italiano Di Tecnologia

Curated by ChEMBL
LigandPNGBDBM50398925(CHEMBL2178787)
Affinity DataKi: >1.00E+5nMAssay Description:Displacement of [3H]Ifenprodil from NMDAR-2B in Sprague-Dawley rat frontal cortex homogenates after 2 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rat)
Istituto Italiano Di Tecnologia

Curated by ChEMBL
LigandPNGBDBM50398916(CHEMBL2178780)
Affinity DataKi: >1.00E+5nMAssay Description:Displacement of [3H]Ifenprodil from NMDAR-2B in Sprague-Dawley rat frontal cortex homogenates after 2 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rat)
Istituto Italiano Di Tecnologia

Curated by ChEMBL
LigandPNGBDBM50398919(CHEMBL2178777)
Affinity DataKi: >1.00E+5nMAssay Description:Displacement of [3H]Ifenprodil from NMDAR-2B in Sprague-Dawley rat frontal cortex homogenates after 2 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rat)
Istituto Italiano Di Tecnologia

Curated by ChEMBL
LigandPNGBDBM50398920(CHEMBL2178776)
Affinity DataKi: >1.00E+5nMAssay Description:Displacement of [3H]Ifenprodil from NMDAR-2B in Sprague-Dawley rat frontal cortex homogenates after 2 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rat)
Istituto Italiano Di Tecnologia

Curated by ChEMBL
LigandPNGBDBM50398921(CHEMBL2178791)
Affinity DataKi: >1.00E+5nMAssay Description:Displacement of [3H]Ifenprodil from NMDAR-2B in Sprague-Dawley rat frontal cortex homogenates after 2 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rat)
Istituto Italiano Di Tecnologia

Curated by ChEMBL
LigandPNGBDBM50398930(CHEMBL2178782)
Affinity DataKi: >1.00E+5nMAssay Description:Displacement of [3H]Ifenprodil from NMDAR-2B in Sprague-Dawley rat frontal cortex homogenates after 2 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rat)
Istituto Italiano Di Tecnologia

Curated by ChEMBL
LigandPNGBDBM50062599(3,5-Dimethyl-adamantan-1-ylamine | CHEMBL807 | EN3...)
Affinity DataKi: >1.00E+5nMAssay Description:Displacement of [3H]Ifenprodil from NMDAR-2B in Sprague-Dawley rat frontal cortex homogenates after 2 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
TargetGlutamate receptor ionotropic, NMDA 2B(Rat)
Istituto Italiano Di Tecnologia

Curated by ChEMBL
LigandPNGBDBM10404((1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetrac...)
Affinity DataKi: >1.00E+5nMAssay Description:Displacement of [3H]Ifenprodil from NMDAR-2B in Sprague-Dawley rat frontal cortex homogenates after 2 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlutamate receptor ionotropic, NMDA 2B(Rat)
Istituto Italiano Di Tecnologia

Curated by ChEMBL
LigandPNGBDBM50030386((1S)-1-methyl-16-azatetracyclo[7.6.1.0^{2,7}.0^{10...)
Affinity DataKi: >1.00E+5nMAssay Description:Displacement of [3H]Ifenprodil from NMDAR-2B in Sprague-Dawley rat frontal cortex homogenates after 2 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
TargetAcid ceramidase(Human)
Fondazione Istituto Italiano Di Tecnologia

Curated by ChEMBL
LigandPNGBDBM29080(CHEMBL280065 | N-oleoylethanolamine | Oleamide MEA...)
Affinity DataKi:  5.00E+5nMAssay Description:Inhibition of acid ceramidase (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSodium-dependent serotonin transporter(Rat)
University of Ferrara

Curated by ChEMBL
LigandPNGBDBM50084717((+)-(1R,2R,3S,5S)-methyl 3-(benzoyloxy)-8-methyl-8...)
Affinity DataIC50:  0.5nMAssay Description:Displacement of [3H]paroxetine from Serotonin transporter of rat caudate putamenMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Rat)
Istituto Italiano Di Tecnologia

Curated by ChEMBL
LigandPNGBDBM50398922(CHEMBL2178790)
Affinity DataIC50:  0.520nMAssay Description:Inhibition of AChE in Wistar rat brain homogenates using acetylthiocholine iodide and DTNB as substrate after 10 mins by Ellman methodMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcid ceramidase(Human)
Fondazione Istituto Italiano Di Tecnologia

Curated by ChEMBL
LigandPNGBDBM367209(2-oxo-4-phenyl-N-(4- phenylbutyl)-1,3- benzoxazole...)
Affinity DataIC50:  0.800nMAssay Description:The assay was performed in Optiplate 96-wells black plates, with each reaction well containing a mixture of 25 mM sodium acetate buffer pH 4.5 and a ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetAcid ceramidase(Human)
Fondazione Istituto Italiano Di Tecnologia

Curated by ChEMBL
LigandPNGBDBM367209(2-oxo-4-phenyl-N-(4- phenylbutyl)-1,3- benzoxazole...)
Affinity DataIC50:  0.800nMAssay Description:Inhibition of recombinant human acid ceramidase expressed in HEK293 cells using N-[(1S,2R)-2-hydroxy-1-(hydroxymethyl)-4-(2-oxochromen-7-yl)-oxybutyl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetTGF-beta receptor type-1(Human)
CHIESI FARMACEUTICI S.P.A.

US Patent
LigandPNGBDBM667068(N-{4-[7-(5-chloro-2-fluorophenyl)- 1H,2H,3H- pyrid...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetTGF-beta receptor type-1(Human)
CHIESI FARMACEUTICI S.P.A.

US Patent
LigandPNGBDBM667069(N-{4-[7-(5-chloro-2-fluorophenyl)- 1H,2H,3H- pyrid...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetTGF-beta receptor type-1(Human)
CHIESI FARMACEUTICI S.P.A.

US Patent
LigandPNGBDBM667070(N-{4-[7-(5-chloro-2-fluorophenyl)- 1H,2H,3H- pyrid...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetTGF-beta receptor type-1(Human)
CHIESI FARMACEUTICI S.P.A.

US Patent
LigandPNGBDBM667071(N-{4-[7-(5-chloro-2-fluorophenyl)- 1H,2H,3H- pyrid...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetTGF-beta receptor type-1(Human)
CHIESI FARMACEUTICI S.P.A.

US Patent
LigandPNGBDBM667072(N-{4-[7-(5-chloro-2-fluorophenyl)- 1H,2H,3H- pyrid...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetTGF-beta receptor type-1(Human)
CHIESI FARMACEUTICI S.P.A.

US Patent
LigandPNGBDBM667073(7-(5-chloro-2-fluorophenyl)-1-{1H- pyrrolo[2,3- b]...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetTGF-beta receptor type-1(Human)
CHIESI FARMACEUTICI S.P.A.

US Patent
LigandPNGBDBM667074(3-[bis(2-hydroxyethyl)amino]-N-{4- [7-(5-chloro-2-...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetTGF-beta receptor type-1(Human)
CHIESI FARMACEUTICI S.P.A.

US Patent
LigandPNGBDBM667075(N-{4-[7-(5-chloro-2-fluorophenyl)- 1H,2H,3H- pyrid...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetTGF-beta receptor type-1(Human)
CHIESI FARMACEUTICI S.P.A.

US Patent
LigandPNGBDBM667076(N-{4-[7-(5-chloro-2-fluorophenyl)- 1H,2H,3H- pyrid...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetTGF-beta receptor type-1(Human)
CHIESI FARMACEUTICI S.P.A.

US Patent
LigandPNGBDBM667077(3-[bis(oxetan-3-yl)amino]-N-{4-[7- (5-chloro-2- fl...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetTGF-beta receptor type-1(Human)
CHIESI FARMACEUTICI S.P.A.

US Patent
LigandPNGBDBM667078(N-{4-[7-(5-chloro-2-fluorophenyl)- 1H,2H,3H- pyrid...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetTGF-beta receptor type-1(Human)
CHIESI FARMACEUTICI S.P.A.

US Patent
LigandPNGBDBM667079(US20240116947, Example 23 | methyl 2-{[2-({4-[7-(5...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetTGF-beta receptor type-1(Human)
CHIESI FARMACEUTICI S.P.A.

US Patent
LigandPNGBDBM667080(N-{4-[7-(5-chloro-2-fluorophenyl)- 1H,2H,3H- pyrid...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetTGF-beta receptor type-1(Human)
CHIESI FARMACEUTICI S.P.A.

US Patent
LigandPNGBDBM667081(N-{4-[7-(5-chloro-2-fluorophenyl)- 1H,2H,3H- pyrid...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetTGF-beta receptor type-1(Human)
CHIESI FARMACEUTICI S.P.A.

US Patent
LigandPNGBDBM667082(N-{4-[7-(5-chloro-2-fluorophenyl)- 1H,2H,3H- pyrid...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetTGF-beta receptor type-1(Human)
CHIESI FARMACEUTICI S.P.A.

US Patent
LigandPNGBDBM667083(N-{4-[7-(5-chloro-2-fluorophenyl)- 1H,2H,3H-pyrido...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetTGF-beta receptor type-1(Human)
CHIESI FARMACEUTICI S.P.A.

US Patent
LigandPNGBDBM667084(N-{4-[7-(5-chloro-2-fluorophenyl)- 1H,2H,3H-pyrido...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetTGF-beta receptor type-1(Human)
CHIESI FARMACEUTICI S.P.A.

US Patent
LigandPNGBDBM667085(N-{4-[7-(5-chloro-2-fluorophenyl)- 1H,2H,3H-pyrido...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetTGF-beta receptor type-1(Human)
CHIESI FARMACEUTICI S.P.A.

US Patent
LigandPNGBDBM667086(3-{4-[2-({4-[7-(5-chloro-2- fluorophenyl)-1H,2H,3H...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetTGF-beta receptor type-1(Human)
CHIESI FARMACEUTICI S.P.A.

US Patent
LigandPNGBDBM667087(N-{4-[7-(5-chloro-2-fluorophenyl)- 1H,2H,3H-pyrido...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetTGF-beta receptor type-1(Human)
CHIESI FARMACEUTICI S.P.A.

US Patent
LigandPNGBDBM667088(N-{4-[7-(5-cyclopropyl-2- fluorophenyl)-1H,2H,3H- ...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetTGF-beta receptor type-1(Human)
CHIESI FARMACEUTICI S.P.A.

US Patent
LigandPNGBDBM667089(N-(4-{7-[2-fluoro-5-(propan-2- yl)phenyl]-1H,2H,3H...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetTGF-beta receptor type-1(Human)
CHIESI FARMACEUTICI S.P.A.

US Patent
LigandPNGBDBM667090(3-{4-[2-({4-[7-(5-chloro-2- fluorophenyl)-1H,2H,3H...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetTGF-beta receptor type-1(Human)
CHIESI FARMACEUTICI S.P.A.

US Patent
LigandPNGBDBM667091(3-(4-{2-[bis(2- hydroxyethyl)amino]ethyl}piperazin...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetTGF-beta receptor type-1(Human)
CHIESI FARMACEUTICI S.P.A.

US Patent
LigandPNGBDBM667092(3-[4-(2-carbamoylethyl)piperazin-1- yl]-N-{4-[7-(5...)
Affinity DataIC50: <1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

Displayed 1 to 50 (of 747 total ) | Next | Last >>
Jump to: